about
sameAs
Gold(I) analogues of a platinum-acridine antitumor agent are only moderately cytotoxic but show potent activity against Mycobacterium tuberculosisInhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin: structural and kinetic aspectsA gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibitionMechanistic studies on a novel, highly potent gold-phosphole inhibitor of human glutathione reductaseGold compounds as therapeutic agents for human diseasesEffect of auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductaseChemical remodelling of cell surfaces in living animalsHistological changes in kidney and liver of rats due to gold (III) compound [Au(en)Cl(2)]ClSusceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolismGold(I)-triphenylphosphine complexes with hypoxanthine-derived ligands: in vitro evaluations of anticancer and anti-inflammatory activitiesQuantum-Sized Gold Nanoclusters: Bridging the Gap between Organometallics and NanocrystalsGold nanoparticles: From nanomedicine to nanosensing.Tiopronin gold nanoparticle precursor forms aurophilic ring tetramer.Surface fragmentation of complexes from thiolate protected gold nanoparticles by ion mobility-mass spectrometryNew structural features in triphenylphosphinesilver(I) sulfanylcarboxylates.Metallosupramolecular Structures Derived from a Series of Diphosphine-bridged Digold(I) Metalloligands with Terminal d-Penicillamine.In Vitro Antitumor Active Gold(I) Triphenylphosphane Complexes Containing 7-Azaindoles.Fabrication of {198Au0} radioactive composite nanodevices and their use for nanobrachytherapy.Identifying potent, selective protein tyrosine phosphatase inhibitors from a library of Au(I) complexes.Gold (I) N-heterocyclic carbene complex inhibits mouse melanoma growth by p53 upregulation.Characterization of thiolate-protected gold nanoparticles by mass spectrometry.Small multifunctional nanoclusters (nanoroses) for targeted cellular imaging and therapy.Synthesis of gold microplates using bovine serum albumin as a reductant and a stabilizerAuranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.Dual-wavelength multifrequency photothermal wave imaging combined with optical coherence tomography for macrophage and lipid detection in atherosclerotic plaques using gold nanoparticles.The golden age: gold nanoparticles for biomedicine.Osmium(VI) complexes as a new class of potential anti-cancer agents.Structural insights into thioredoxin-2: a component of malaria parasite protein secretion machinery.Unexpected toxicity of monolayer protected gold clusters eliminated by PEG-thiol place exchange reactions.Enhancement of auranofin-induced apoptosis in MCF-7 human breast cells by selenocystine, a synergistic inhibitor of thioredoxin reductase.Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanismsRepair of abdominal wall defects in vitro and in vivo using VEGF sustained-release multi-walled carbon nanotubes (MWNT) composite scaffolds.Synthesis and anti-cancer activities of a water soluble gold(III) porphyrin.125I-labeled gold nanorods for targeted imaging of inflammation.Chlorido{N-[(E)-2-(diphenyl-phosphan-yl)benzyl-idene]-2-(thio-phen-2-yl)ethan-amine-κP}gold(I)Metal and metalloid containing natural products and a brief overview of their applications in biology, biotechnology and biomedicine.Anticancer Gold(III) Porphyrins Target Mitochondrial Chaperone Hsp60.Gold-containing indoles as anticancer agents that potentiate the cytotoxic effects of ionizing radiation.Intrinsic therapeutic applications of noble metal nanoparticles: past, present and futureOn the mechanism and rate of gold incorporation into thiol-dependent flavoreductases
P2860
Q24635912-7FE561A1-75F3-4BC5-89BB-99EF17E033D2Q24652462-6FA4344B-EE66-430B-A391-0B5662EA1D61Q27671675-E6A1D779-BFA4-4B9E-92C6-E899F1635654Q28241851-44AFC139-4FCB-4C90-94AF-5E8CCC32B580Q28243207-6893DFE6-D3A9-40DD-90D7-03F8955CEF46Q28263095-EE07AC8B-571A-4AA9-84FC-197F280A7591Q28277825-C5C01CA2-DF60-475C-A2FF-2B4AC68E2230Q28484603-8F68EDE2-97D7-4419-B0AE-BD535F14C926Q28484655-7B3EC1C7-0C02-4891-909E-9B8B7ECBDFA4Q28543014-917E5DF7-1186-413B-93F8-B44CE1AD4CC4Q29308130-AE84F0DA-1689-4BD4-BA4C-FA64E0D69581Q30447539-47E2342D-FAB2-4727-B1FF-29BF11BF620DQ30497507-06E30A82-0B43-49D2-B631-FF635E5DC505Q30979569-3EE31929-CA2B-4F2B-BC4A-E761CBB4D6CAQ30988037-CABD03B1-D69F-4152-B4BA-5F3D94AF2500Q31102860-F606F40C-5A26-4F07-90C0-72C2D12929B0Q31148784-B798515B-05D4-4873-8107-3076DE707A1FQ33318156-F8E734F9-889A-41D0-989E-F717A179E09DQ33514906-2B9C96F6-404F-4E5A-A47E-4F3338AD5D29Q33557744-7DB169C8-4308-4A32-8455-1144A271B362Q33564497-EC5534DC-38EE-4AD5-B668-34DD3348B469Q33740377-876E93BF-A6B6-4DCD-BF43-9E8BDB50DA49Q33761845-481AD7AF-4339-461D-B3B1-2F3FAAB5798EQ33829292-321FEC96-620E-4A4C-A159-6D87BA589D58Q33901369-03736008-4061-4879-B26A-A9891EBB845FQ34081123-809473F6-9A6C-4C66-B57A-C132D60BC0A7Q34157363-C963F85F-2804-4A45-B0D6-6D8325D7A738Q34166647-6535E8F9-7635-4D88-92AA-E42818F5668FQ34338587-8E92385A-A100-4B41-8BC5-81F932FD8316Q34558945-BCCB4E0C-E4E1-4792-8CC7-D2E8FC3068C1Q34619261-78941D1E-479E-4531-A5AF-788FD2C3143FQ34745767-A7A95088-E484-4E29-B170-07D9C7829B90Q35530076-F68072B7-104F-4748-B3CB-112025561226Q35569270-C8B466FE-A3CC-437B-9A4F-4CEBBB8DD33AQ35662336-5737E644-0056-4628-82B0-1E637A1C2314Q35836648-F7D32D0D-412F-41DC-9194-C5623D89C62DQ35867952-0BCD5E5E-5AB8-4337-A9A7-140423457ECCQ35889822-315B4E07-13CC-4AC8-BB5D-7CFBAFEC4EFFQ35942437-7669BDBA-EAB0-4A17-AFE5-A5DC27AA09AEQ36094494-7A231464-4CF9-4029-9B6B-25D86DDB48AB
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Gold-based therapeutic agents
@ast
Gold-based therapeutic agents
@en
Gold-based therapeutic agents
@nl
type
label
Gold-based therapeutic agents
@ast
Gold-based therapeutic agents
@en
Gold-based therapeutic agents
@nl
prefLabel
Gold-based therapeutic agents
@ast
Gold-based therapeutic agents
@en
Gold-based therapeutic agents
@nl
P356
P1433
P1476
Gold-based therapeutic agents
@en
P2093
C F Shaw III
P304
P356
10.1021/CR980431O
P407
P577
1999-09-08T00:00:00Z